| Species : | Human | 
                                
                                    | Source : | HEK293 | 
                                
                                    | Tag : | Non | 
                                
                                    | Description : | Teratocarcinoma-derived growth factor 1 is the founding member of the EGF-CFC gene family, which is conserved among vertebrates. Proteins within this family contain a signal sequence, a characteristic EGF-like domain, a cysteine-rich region termed the cryptic (CFC) motif, and a hydrophobic C? terminus. It has been reported that Cripto-1 is O-fucosylated on Thr-88 and that this modification is required for the physical interaction with Nodal as well as for signalling activity. We have confirmed that teratocarcinoma-derived growth factor 1 is O-fucosylated at this site. | 
                                
                                    | Amino Acid Sequence : | LGHQEFARPSRGYLAFRDDSIWPQEEPAIRPRSSQRVPPMGIQHSKELNRTCCLNGGTC MLGSFCACPPSFYGRNCEHDVRKENCGSVPHDTWLPKKCSLCKCWHGQLRCFPQAFL PGCDGLVMDEHLVASRTPELPPS. | 
                                
                                    | Molecular Mass : | Under reducing conditions teratocarcinoma-derived growth factor 1 migrates as a broad band between 20 and 30 kDa on SDS-PAGE due to post-translational modifications, in particular glycosylation. This compares with unmodified Cripto-1 polypeptide that has a predicted monomeric molecular mass of 15.6 kDa. | 
                                
                                    | pI : | Teratocarcinoma-derived growth factor 1 has a predicted pI of 8.04. | 
                                
                                    | % Carbohydrate : | Purified teratocarcinoma-derived growth factor 1 consists of 20-50% carbohydrate by weight. | 
                                
                                    | Glycosylation : | Teratocarcinoma-derived growth factor 1 contains N- and O-linked oligosaccharides with confirmed O-fucosylation at Thr-88. | 
                                
                                    | Purity : | >95%, as determined by SDS-PAGE, visualised by Coomassie Brilliant Blue. | 
                                
                                    | Formulation : | When reconstituted in 0.5 ml sterile phosphate-buffered saline, the solution will contain 1% human serum albumin (HSA) and 10% trehalose. | 
                                
                                    | Reconstitution : | It is recommended that 0.5 ml of sterile phosphate-buffered saline be added to the vial. | 
                                
                                    | Storage : | Lyophilised products should be stored at 2 to 8°C. Following reconstitution short-term storage at 4°C is recommended, with longer-term storage in aliquots at -18 to -20°C. Repeated freeze thawing is not recommended. | 
                                
                                    | Activity : | Teratocarcinoma-derived growth factor 1 has been shown to stimulate MAPK phosphorylation in HUVEC cells. 200ng/ml is sufficient to stimulate phosphorylation. |